Global Ganja Report

Cannabis industry leaders have announced certification standards to promote corporate responsibility. The move appears to be prompted by some embarrassing scandals in the young industry. Activists are meanwhile raising more far-reaching demands for drug war "reparations." 

Harborside, the San Francisco Bay Area's flagship cannabis dispensary chain, is going public on the Canadian stock exchange. Founder and chairman emeritus of the company, Steve DeAngelo, speaks with Cannabis Now about what this means for Harborside's future and the fast-evolving cannabis industry.

As New Zealand waits on a promised cannabis legalization referendum, a domestic industry is starting to blossom, with big capital inflows reported. But police cannabis seizures are actually up—and the government even shows sings of wavering on following through with its commitment to hold a binding referendum.

A showdown is shaping up in Vancouver, where the city's 420 event has always been held with no permit. This year it promises to be huge, with Cypress Hill headlining—and authorities pressing for cancellation. Organizers pledge the event will go ahead—with approval of the bureaucracy or not.

There is a growing consensus among hemp advocates that the 0.3% limit for THC content is arbitrary and is holding back the industry. And the man widely credited with arriving at this limit himself agrees.

The Contested Border
"It seems like it is pretty much pulled out of air. We ought to be looking to science to determine an appropriate threshold, determine the level at which cannabis is psychoactive and make that the standard."

This typical view is offered by attorney Patrick Goggin of Hoban Law Group, the international firm specializing in cannabis. Goggin is one of the industry's legal heavy-hitters, and has particular experience in the question of the contested border between hemp and marijuana.

Insurance companies in Canada are starting to cover medical marijuana, but high costs continue to be an impediment to access in the United States. Even in states that have legalized medicinal use of cannabis, the insurance industry will provide no coverage. Advocates are now starting to demand legislation to address this contradiction.

As a commercial cannabis industry is established in Jamaica, more Caribbean nations are moving toward decriminalization and establishing medical marijuana programs. Saint Vincent & the Grenadines was the latest to take this move, and it looks like Saint Kitts & Nevis will be next. Dominica and Grenada are studying such proposals, and cannabis tourism is anticipated.

As demands mount for expungement of cannabis convictions in the 10 states that have legalized, as well as in Canada, the cumbersome bureaucracy of court systems is an obstacle. Now San Francisco has teamed with a software company to automate the process—a partnership that could serve as a model for other jurisdictions across North America.